Innovent Receives IND Approval to Initiate Clinical Trials in China with its anti-OX40 Agonistic Antibody IBI101 and its anti-RANKL Antibody IBI307 Life Science
Donald Trump announces ‘very big day’ in US-EU trade war as European leaders agree to resolve issues Others, Technology
Luye Pharma Well Positioned for CNS Market with the Approval of A New Indication for Seroquel XR in China Life Science
BeiGene Shows Off Strong Results from Checkpoint Inhibitor While Eying Potential Approval for BTK Inhibitor Life Science